01
Cash & equivalents increased 40.6%
Cash & equivalents changed +40.6% from the comparable as-filed period.
$117.3M→$165.0MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTViridian Therapeutics, Inc.\DE's latest supported as-filed period reports revenue of $4.8M. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +40.6% from the comparable as-filed period.
Net income changed -26.2% from the comparable as-filed period.
Operating income changed -18.3% from the comparable as-filed period.
Stock-based compensation changed +56.6% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
VRDN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-359636SEC ↗4Aug 18, 2026Period Aug 14, 20260001193125-26-355735SEC ↗10-QAug 6, 2026Period Jun 30, 20260001590750-26-000018SEC ↗8-KAug 6, 2026Period Aug 6, 20260001193125-26-336691SEC ↗4Jul 2, 2026Period Jul 1, 20260001193125-26-294561SEC ↗4Jul 2, 2026Period Jul 1, 20260001193125-26-294560SEC ↗4Jul 2, 2026Period Jul 1, 20260001193125-26-294556SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 19, 2026Filed Aug 20, 2026 | Tousignant JenniferChief Legal Officer | Open Market SaleDirect | 4,212 | $25 | $103,194 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Tousignant JenniferChief Legal Officer | Option ExerciseDirect | 10,000 | $14 | $144,100 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Tousignant JenniferChief Legal Officer | Open Market SaleDirect | 10,000 | $25 | $245,000 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Tousignant JenniferChief Legal Officer | Option ExerciseDirect | 10,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-294552